Alternative management of proximal aortic dissection: concept and application
File(s)Yuan2022_Article_AlternativeManagementOfProxima.pdf (978.58 KB)
Published version
Author(s)
Yuan, Xun
Mitsis, Andreas
Mozalbat, David
Nienaber, Christoph
Type
Journal Article
Abstract
Open surgery remains the mainstay of treatment for acute type A aortic dissection and should be offered to most patients. However, there are elderly patients in which surgical treatment may be deemed extremely high risk or futile. Endovascular treatment approaches have been applied to a small number of these patients and data are limited to case reports and small series. The application of endovascular therapies to ascending aorta is currently limited by anatomical and technical challenges posed by the dynamic motion of the ascending aorta and the proximity of vital structures to intended landing zones (aortic valve, coronary arteries, and supra-aortic branches) and lack of specially designed endografts to address these issues.
While thoracic endovascular aortic repair (TEVAR) has replaced open aortic repair for suitable lesion in distal aortic dissection, some selected patients with type A aortic dissection at high surgical may be candidates. Hence, there is potential because in proximal (Stanford type A) dissections, 10-30% of patients are not accepted for surgery, and 30-50% is technically amenable for TEVAR. Recent experience has shown that carefully selected patients with favourable anatomical characteristics may be subject to endovascular stent-graft treatment as a last resort with mixed results. Technical improvement is necessary to offer. satisfactory endovascular options in non-sugical candidates.
While thoracic endovascular aortic repair (TEVAR) has replaced open aortic repair for suitable lesion in distal aortic dissection, some selected patients with type A aortic dissection at high surgical may be candidates. Hence, there is potential because in proximal (Stanford type A) dissections, 10-30% of patients are not accepted for surgery, and 30-50% is technically amenable for TEVAR. Recent experience has shown that carefully selected patients with favourable anatomical characteristics may be subject to endovascular stent-graft treatment as a last resort with mixed results. Technical improvement is necessary to offer. satisfactory endovascular options in non-sugical candidates.
Date Issued
2022-04-01
Date Acceptance
2021-10-01
Citation
Indian Journal of Thoracic and Cardiovascular Surgery, 2022, 38, pp.183-192
ISSN
0970-9134
Publisher
Springer Verlag
Start Page
183
End Page
192
Journal / Book Title
Indian Journal of Thoracic and Cardiovascular Surgery
Volume
38
Copyright Statement
© The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
License URL
Subjects
Science & Technology
Life Sciences & Biomedicine
Cardiac & Cardiovascular Systems
Cardiovascular System & Cardiology
Proximal aortic dissection
TEVAR
Endovascular
Occluder
Coils
FALSE-LUMEN THROMBOSIS
ENDOVASCULAR REPAIR
STENT-GRAFT
A DISSECTION
INTERNATIONAL-REGISTRY
ASCENDING AORTA
HIGH-RISK
TRANSESOPHAGEAL ECHOCARDIOGRAPHY
ARCH
ENDOGRAFT
Publication Status
Published
Date Publish Online
2021-12-13